Biotherapeutic Modalities

Biotherapeutics, often known as biologicals, are medication therapy products in which the active ingredient is derived from a biological source. Recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, growth factors, gene therapy products, vaccines, cell-based goods, gene-silencing/editing therapies, tissue-engineered products, and stem cell therapies are just a few examples of these products. mAbs are the most quickly increasing therapy class in oncology, anti-immunity, and chronic inflammatory illnesses, with a large number of biotherapeutic compounds in development or newly approved. Apoptosis in cells that express the target (antigen), inhibiting specific molecular processes, and/or altering signalling pathways are all therapeutic strategies used by monoclonal antibodies. Biotherapeutics are a rapidly developing segment of the pharma industry, accounting for over half of all new drug approvals in recent years. Different terminologies refer to different subcategories of therapies within the general biopharmaceutical category, and terminology surrounding biopharmaceuticals differs amongst organisations and entities. Some regulatory agencies refer to engineered macromolecular products like protein- and nucleic acid-based drugs as biological medicinal products or therapeutic biological products, distinguishing them from products like blood, blood components, or vaccines, which are usually extracted directly from a biological source.

• Cytokines
• Growth Factors
• Hormones
• Interferons
• Regulatory Peptides And Proteins
• Novel Cell Lines
• Biotherapeutic Product Standardization
• Predictive Toxicology
• Biopharmaceutics
• Biopharmacology